TY - JOUR
T1 - A Parade of Persistent and Emerging Contact Allergens - A Clinical Update
AU - Ahlstrom, Malin Glindvad
AU - Uter, Wolfgang
AU - Schwensen, Jakob Ferlov Baselius
AU - Larsen, Christoffer Kursawe
AU - Sogaard, Rebekka
AU - Johansen, Jeanne Duus
PY - 2026
Y1 - 2026
N2 - Purpose of Review Clinical management of allergic contact dermatitis (ACD) is increasingly challenging due to the grow-ing number of allergens, complex exposure patterns, and evolving regulatory frameworks. This review aims to provide clinicians with an updated overview of well-known as well as new and emerging allergens relevant to the diagnosis and management of ACD. Recent Findings Recent literature highlights changing exposure patterns and the identification of several new and emerg-ing allergens, particularly in rapidly expanding consumer markets such as cosmetics and products associated with medical devices. In addition, updated evidence has refined the clinical relevance of established allergen groups, including fragrances, metals, rubber chemicals, acrylates, and preservatives. Post-marketing surveillance of products and clinical patch test data continue to play an important role in detecting novel sensitizers and shifting exposure scenarios. Summary Clinicians must remain vigilant, as exposure patterns continue to evolve with the introduction of new ingredients and products while established allergens persist. Ongoing surveillance and updated clinical awareness are essential to ensure accurate diagnosis and prevention of ACD.
AB - Purpose of Review Clinical management of allergic contact dermatitis (ACD) is increasingly challenging due to the grow-ing number of allergens, complex exposure patterns, and evolving regulatory frameworks. This review aims to provide clinicians with an updated overview of well-known as well as new and emerging allergens relevant to the diagnosis and management of ACD. Recent Findings Recent literature highlights changing exposure patterns and the identification of several new and emerg-ing allergens, particularly in rapidly expanding consumer markets such as cosmetics and products associated with medical devices. In addition, updated evidence has refined the clinical relevance of established allergen groups, including fragrances, metals, rubber chemicals, acrylates, and preservatives. Post-marketing surveillance of products and clinical patch test data continue to play an important role in detecting novel sensitizers and shifting exposure scenarios. Summary Clinicians must remain vigilant, as exposure patterns continue to evolve with the introduction of new ingredients and products while established allergens persist. Ongoing surveillance and updated clinical awareness are essential to ensure accurate diagnosis and prevention of ACD.
KW - Acrylates
KW - Allergic contact dermatitis
KW - Contact allergy
KW - Cosmetovigilance
KW - Fragrances
KW - Metals
KW - Preservatives
KW - Rubber
U2 - 10.1007/s11882-026-01270-9
DO - 10.1007/s11882-026-01270-9
M3 - Review
C2 - 41920264
SN - 1529-7322
VL - 26
JO - Current Allergy and Asthma Reports
JF - Current Allergy and Asthma Reports
IS - 1
M1 - 28
ER -